PCSK9 and acute kidney injury: Furthermore, the risk stratification analysis revealed a significantly greater protective effect of PCSK9 inhibitors in high- and extremely high-risk groups than in low- and middle-risk groups, providing novel insights and approaches for preventing CA-AKI in high-risk individuals.